bcbsma glp-1 coverage Blue Cross Blue Shield will stop covering popular weight-loss drugs amid surging costs bcbs ma glp 1 coverage

Clinical studies show that approximately 50% to 70% of lost weight is regained within a year of discontinuation, which underscores the challenge of achieving lasting results

Comment: A few commenters requested excluding this measure from Overall Hospital Star Ratings and performance-based quality reporting programs

Among the issues were inconsistent naming, missing or inadequate descriptions of physical and chemical properties, incomplete impurity information, limited analytical detail, and uncertainty about how marketed materials correspond to the nominated substances

After adjusting for potentially influential factors, including age, sex, ethnicity, pre-existing conditions, other medication use and body mass index (BMI), use of GLP-1 receptor agonists was associated with a 37% higher risk of alopecia than use of SGLT-2 inhibitors (6.91 v 5.04 per 1,000 person years) and a 68% higher risk than use of DPP-4 inhibitors (6.53 v 3.89 per 1,000 person years)